Cargando…
Anticancer Effects of Dihydroartemisinin on Human Esophageal Cancer Cells In Vivo
Despite recent advances in chemotherapy and surgical resection, the 5-year survival rate of esophageal cancer still remains at the low level. Therefore, it is very important to discover a new agent to improve the life expectancy of patients with esophageal cancer. Dihydroartemisinin (DHA), a semisyn...
Autores principales: | Jiang, Cailing, Li, Shumin, Li, Yanjing, Bai, Yuxian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985077/ https://www.ncbi.nlm.nih.gov/pubmed/29888170 http://dx.doi.org/10.1155/2018/8759745 |
Ejemplares similares
-
Autophagy-dependent cell cycle arrest in esophageal cancer cells exposed to dihydroartemisinin
por: Ma, Qiang, et al.
Publicado: (2020) -
Evaluation of the Anticancer Activity of a Bile Acid-Dihydroartemisinin Hybrid Ursodeoxycholic-Dihydroartemisinin in Hepatocellular Carcinoma Cells
por: Huang, Tzu-En, et al.
Publicado: (2020) -
Human Telomerase Reverse Transcriptase as a Therapeutic Target of Dihydroartemisinin for Esophageal Squamous Cancer
por: Li, Qingrong, et al.
Publicado: (2021) -
Dihydroartemisinin inhibits the migration of esophageal cancer cells by inducing autophagy
por: Chen, Xiao, et al.
Publicado: (2020) -
Dihydroartemisinin: A Potential Natural Anticancer Drug
por: Dai, Xiaoshuo, et al.
Publicado: (2021)